2006 executive compensation survey.In 2006, the Securities and Exchange Commission's new disclosure rules for executive compensation went into effect. These rules provide investors with a more accurate outline regarding the compensation of top executives and directors of US public companies. The most significant changes include disclosure of annual total compensation, annual change in pension value and annual, nonqualified deferred compensation (this usually refers to deferred compensation for which there is no tax write-off Write-Off A reduction in the value of an asset or earnings by the amount of an expense or loss. Companies are able to write off certain expenses that are required to run the business, or have been incurred in the operation of the business and detract from retained revenues. in the given year); severance The act of dividing, or the state of being divided. The term severance has unique meanings in different branches of the law. Courts use the term in both civil and criminal litigation in two ways: first, when dividing a lawsuit into two or more parts, and second, when benefits; and perquisites Fringe benefits or other incidental profits or benefits accompanying an office or position. The abbreviation perks is used in reference to extraordinary benefits afforded to business executives, such as country club memberships or the free use of automobiles. or other personal items that exceed $10,000. The new rules apply only to companies that have a fiscal year end of December December: see month. 15, 2006 or later. To provide a more accurate total for the executive compensation in fiscal year 2006, IBO Ibo: see Igbo. has included the fair value of stock and option awards on the date they were granted. The 2006 IBO Executive Compensation Survey includes 61 executives from 42 companies and is based upon the companies currently in IBO's three Stock Indexes (see IBO 4/30/07) and Becton Dickinson BD (NYSE: BDX), is a medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs 27,000 people in nearly 50 countries. . QIAGEN Wikipedia is not the place for advertisement or self-advertising. QIAGEN (NASDAQ: QGEN, FWB: QIA) is a provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics. , Nanometrics, Stratagene and Molecular Devices Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. are excluded as a result of incomplete filings. To create the tables, IBO selected one or two executives for each company who best reflect the company's laboratory products or analytical analytical, analytic pertaining to or emanating from analysis. analytical control control of confounding by analysis of the results of a trial or test. instruments business. For each executive, IBO compiled the annual salary, bonus, nonequity incentive plan and "other" compensation ("other" includes change in pension value, nonqualified deferred compensation earnings and perquisites over $10,000) in order to determine total short-term Short-term Any investments with a maturity of one year or less. short-term 1. Of or relating to a gain or loss on the value of an asset that has been held less than a specified period of time. compensation for fiscal 2006. Long-term Long-term Three or more years. In the context of accounting, more than 1 year. long-term 1. Of or relating to a gain or loss in the value of a security that has been held over a specific length of time. Compare short-term. compensation is determined based on the grant-date fair value of stock and option awards. These figures provide an account of equity securities awarded to executives in the most recent fiscal year. In previous years, IBO used the market value of restricted stock and the value of options granted multiplied mul·ti·ply 1 v. mul·ti·plied, mul·ti·ply·ing, mul·ti·plies v.tr. 1. To increase the amount, number, or degree of. 2. Mathematics To perform multiplication on. by the average exercise price to determine the total long-term compensation. To more accurately reflect the proposed total compensation by the company directors, IBO now uses a fair market value for option and stock awards. Total compensation consists of annual short-term and long-term compensation. Also included in the tables are the options exercised by the executive during fiscal 2006. In 2006, average total short-term executive compensation jumped 31.4% to $1,254,978 compared to a decline of 7.2% in 2005. An increase was expected following the addition of nonequity incentive compensation and new perquisite per·qui·site n. 1. A payment or profit received in addition to a regular wage or salary, especially a benefit expected as one's due. See Synonyms at right. 2. A tip; a gratuity. 3. rules. Previously, only personal benefits of $50,000 or 10% of the executive's annual base salary and bonus were included. The average base salary declined a modest 0.4% to $480,430, while the average bonus declined 29.5% to $278,540. Certain compensation previously reported as a bonus is now reported as nonequity incentive compensation. Undetermined performance-related bonuses are listed as nonequity compensation, while any non-performance-related compensation or uncommunicated bonus to an executive is reported as a bonus. The average bonus received by the 27 executives who were awarded bonuses in 2006 was $589,733; in comparison, the average bonus received by the 45 executives in 2005 was less than half at $279,749. The average nonequity payment for an executive eligible under an incentive plan was $511,305. More than half of the executives received nonequity incentive compensation. Also, as expected, due to new disclosure regulations, all "other" compensation increased significantly from the previous year. Excluding a one-time one-time adj. 1. or one·time a. Occurring or undertaken only once: a one-time winner in 1995. b. severance package A severance package is pay and benefits an employee receives when they leave employment at a company. In addition to the employee's remaining regular pay, it may include some of the following:
Fédération Équestre Internationale. , the average "other" compensation climbed 32.7% to $284,783. The average total long-term compensation, including both fair value stock and options awards, was $929,447. Only four executives in the tables, three of whom have recently resigned, did not receive some form of long-term stock or option compensation. The new disclosure rules for total compensation helped increase the total average compensation to $3,113,873 for fiscal 2006. Unfortunately, we cannot accurately compare this amount to the preceding year as a result of different calculation methods. However, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Mercer Human Resource Consulting Mercer Human Resource Consulting is a human resource consulting firm that publishes the oft-quoted "Worldwide Cost of Living Survey." External links
The Laboratory Instruments Index table (see following page) includes 35 executives from 23 companies. The average 2006 short-term compensation increased 24.5% to $1,125,496 and the average base salary rose 4.0% to $493,966. While several base salaries remained constant, the largest salary increase was for Frank Laukien, CEO and president of Bruker Bruker originally started as a German company specialized in nuclear magnetic resonance (NMR), but has evolved into an international company with products covering a gamut of biological, chemical and medical fields. There are two companies that carry the Bruker brand. BioSciences. His salary rose 26.2 % to $295,000. The largest reported salary in the Laboratory Instruments Index table was $1,096,154 for Tony White, CEO and president of Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. . The average bonus for the Index was $277,376, and the average bonus for those who qualified for a payment in 2006 was up 33% to $693,439. More than 80% of the executives received some sort of bonus; 16 executives received a nonequity incentive payment, 12 were awarded bonuses and two qualified for both bonus and nonequity compensation. The total average compensation for the table was $3,140,554. Some of the most notable payouts include Marijn E. Dekkers, CEO and president of Thermo Fisher Scientific Fisher Scientific, formally Fisher Scientific International, Inc. and colloquially Fisher was a biotechnology company that provided products and services to the global scientific research and United States clinical laboratory markets. , whose total compensation amounted to $20.2 million, the largest among all tables. The employment agreement for Mr. Dekkers currently provides for an annual base salary of $1,050,000 and a target annual incentive bonus of 110% of base salary. The actual amount paid as a bonus in any given year is a multiple of zero to two times the target amount. Not to be outdone out·do tr.v. out·did , out·done , out·do·ing, out·does To do more or better than in performance or action. See Synonyms at excel. , Gregory Summe, the president and CEO of PerkinElmer PerkinElmer, Inc. (NYSE: PKI) is an American multinational technology corporation, focused in the business areas of: Life and Analytical Sciences, Optoelectronics, and Fluid Sciences. , earned the highest short-term compensation, totaling $4,411,063. Mr. Summe received a total nonequity bonus of $2,806,000, of which $1,250,000 was based on short-term incentive and individual performance and $1,556,100 was attributed to performance goals based on earnings per share. Mr. Summe was also awarded $147,336 for use of the company's aircraft in which it owns a fractional fractional size expressed as a relative part of a unit. fractional catabolic rate the percentage of an available pool of body component, e.g. protein, iron, which is replaced, transferred or lost per unit of time. interest. During 2006, there were many changes among executives. Transgenomic hired Mr. Tuttle Tuttle may refer to:
n. 1. A very pure form of gelatin. J. D'Silva (see IBO 8/15/06). Robert Robert, Henry Martyn 1837-1923. American army engineer and parliamentary authority. He designed the defenses for Washington, D.C., during the Civil War and later wrote Robert's Rules of Order (1876). Noun 1. Friel Friel is a surname, and may refer to
tr.v. ap·point·ed, ap·point·ing, ap·points 1. To select or designate to fill an office or a position: appointed her the chief operating officer of the company. 2. divisional president for PerkinElmer, replacing Peter Coggins, who retired in February February: see month. 2006 (see IBO 1/31/06). Also, ensuing en·sue intr.v. en·sued, en·su·ing, en·sues 1. To follow as a consequence or result. See Synonyms at follow. 2. To take place subsequently. the acquisition of Amazys, Thomas (language) Thomas - A language compatible with the language Dylan(TM). Thomas is NOT Dylan(TM). The first public release of a translator to Scheme by Matt Birkholz, Jim Miller, and Ron Weiss, written at Digital Equipment Corporation's Cambridge Research Laboratory runs J. Vacchiano, Jr. was appointed the new president and CEO of X-Rite X-Rite, Inc. is a manufacture of color matching products located in Kentwood, Michigan, United States. Their products include those used for matching paint colors (Totalizing Fluid Meter and Counting Device Manufacturing). , while Michael Michael, archangel Michael (mī`kəl) [Heb.,=who is like God?], archangel prominent in Christian, Jewish, and Muslim traditions. In the Bible and early Jewish literature, Michael is one of the angels of God's presence. C. Ferrara Ferrara (fār-rä`rä), city (1991 pop. 138,015), capital of Ferrara prov., in Emilia-Romagna, N Italy. It is a rich industrial and agricultural center, located on a low-lying, marshy plain that has much reclaimed land. retired from his position of CEO on October October: see month. 1, but remains a nonofficer employee of the company (see IBO 11/15/06). Edward Edward killed his father at his mother’s instigation. [Br. Balladry: Edward in Benét, 302] See : Patricide J. Ludwig Ludwig. For German rulers thus named, use Louis. , CEO of Becton Dickinson, received "other" compensation of $60,790 for personal use of company-owned aircraft. Additionally, Mr. Ludwig has arranged a time-share time-share v. time-shared, time-shar·ing, time-shares v.tr. 1. Computer Science To use (a computer) by time-sharing. 2. To occupy (a vacation property) by time-sharing. v. plan for personal use of the company-owned aircraft for which he makes aggregate payments of $94,450 to the company. For the Process/Metrology/Motion Instrumentation instrumentation, in music: see orchestra and orchestration. instrumentation In technology, the development and use of precise measuring, analysis, and control equipment. Index (see preceding page), the average short-term compensation improved over 200% to $1,933,061, as a result of a large compensation package to the former president and CEO of FEI. Vahe A. Sarkissian, who resigned effective April 1 (see IBO 8/15/06), received a severance package valued at over $8,996,945, which included the acceleration acceleration, change in the velocity of a body with respect to time. Since velocity is a vector quantity, involving both magnitude and direction, acceleration is also a vector. In order to produce an acceleration, a force must be applied to the body. of all of his stock options and restricted stock awards. Excluding the large compensation package, short-term compensation increased 3.8% to $647,783 and total compensation averaged $1,898,655. Apart from Mr. Sarkissan, all executives received either a bonus or nonequity incentive payment. The average bonus for those who received one jumped 137% to $483,913, due to the employment package received by Don R. Kania. As the newly appointed president and CEO of FEI (see IBO 8/15/06), Dr. Kania received a $750,000 bonus, 300,000 option shares with an base price of $19.38, a 150,000-share stock award, relocation RELOCATION, Scotch law, contracts. To let again to renew a lease, is called a relocation. 2. When a tenant holds over after the expiration of his lease, with the consent of his landlord, this will amount to a relocation. reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. totaling $218,651 and reimbursement of $19,246 for legal fees associated with his employment agreement. The average short-term compensation for executives in the Laboratory Consumables-Equipment Index (see page 5) dropped 9.9% to $915,349. The average base salary dropped 3.7% to $479,145, due to the CEO change at Sigma-Aldrich. Effective January January: see month. 1, 2006, Jai P. Nagarkatti replaced David R. Harvey Harvey, city (1990 pop. 29,771), Cook co., NE Ill., a suburb S of Chicago; inc. 1895. Its manufactures include steel castings, metal products, chemicals, machinery, and electronic equipment. Harvey has an oil research center. The city was founded by Turlington W. as CEO of Sigma-Aldrich (see IBO 3/31/06). In connection with his promotion, Dr. Nagarkatti received a base salary increase from $470,000 to $600,000. Consequently, the salary of Dr. Harvey, now the chairman, was reduced from $725,000 to $250,000. Excluding both individuals from the table, the average base salary improved 4.3% to $492,682. Eric ERIC Educational Research Information Clearinghouse ERIC Educational Resources Information Center ERIC ERISA Industry Committee ERIC Epidemiologic Research and Information Center (Durham, NC) Krasnoff, CEO of Pall, received an $865,815 bonus based on the company's favorable fa·vor·a·ble adj. 1. Advantageous; helpful: favorable winds. 2. Encouraging; propitious: a favorable diagnosis. 3. return on equity and elected e·lect v. e·lect·ed, e·lect·ing, e·lects v.tr. 1. To select by vote for an office or for membership. 2. To pick out; select: elect an art course. to receive $632,626 of the value in the form of restricted stock. New Brunswick's CEO, David Freedman  This article or section resembles a .Please help [ improve this article] by removing excessive trivia, irrelevant praise and criticism, lists and collections of links that are of . , retired effective December 31, 2006. His successor 1. SuccessoR - A language for distributed computing derived from SR. ["SuccessoR: Refinements to SR", R.A. Olsson et al, TR 84-3, U Arizona 1984]. 2. successor - daughter is the current president and COO (Cell Of Origin) See mobile positioning. James James, person in the Bible James, in the Gospel of St. Luke, kinsman of St. Jude. The original does not specify the relationship. James, rivers, United States James. Orcutt (see IBO 2/28/07). Mr. Freedman freed·man n. A man who has been freed from slavery. freedman Noun pl -men History a man freed from slavery Noun 1. received a performance bonus of $94,283 for meeting the company's 2006 goals and a $396,000 recognition bonus. The Diversified diversified (di·verˑ·s Instrumentation Index (see page 6) was not included in the 2005 survey. The average salary, bonus and nonequity incentives top all other Indexes at $533,865, $264,828 and $498,085, respectively. The Index also represents the largest average total compensation of $4,078,687. Accordingly, the average market capitalization Market Capitalization A measure of a public company's size. Market capitalization is the total dollar value of all outstanding shares. It's calculated by multiplying the number of shares times the current market price. This term is often referred to as market cap. and operating profit Operating profit (or loss) Revenue from a firm's regular activities less costs and expenses and before income deductions. operating profit See operating income. for the Diversified Instrumentation Index far exceeds the other Indexes. F. S. Hermance Hermance is a municipality of the Canton of Geneva, Switzerland. External links
relating to relate prep → bezüglich +gen, mit Bezug auf +acc operating group performance measures. Danaher's executive vice president, Steven Ste´ven n. 1. Voice; speech; language. Ye have as merry a steven As any angel hath that is in heaven. - Chaucer. 2. An outcry; a loud call; a clamor. To set steven to make an appointment. E. Simms Simms may refer to: First or middle name
v. de·ferred, de·fer·ring, de·fers v.tr. 1. To put off; postpone. 2. To postpone the induction of (one eligible for the military draft). v.intr. $750,000 of his $900,000 nonequity incentive compensation into the company's deferred incentive program. In addition to the lucrative nonequity incentive bonus earned by Roper's CEO and president, Brian The name Brian (sometimes spelled Bryan) comes from an Irish backround. It is of Celtic origin and its meaning may be "hill" or "strong, noble, and high"[1]. Jellison, he also received perquisites of $6,112 for club memberships, $24,000 for a company car and $159,007 for relocation. These new disclosure rules may have the effect of requiring company directors to justify what is considered fair and competitive compensation, which has a direct effect on shareholders.
Top 10 Total Compensation, 2006
Company Executive Total Pay
Thermo Fisher Scientific Marijin E. Dekkers $20,253,106
Roper Industries Brian D. Jellison $9,647,760
Thermo Fisher Scientific Mark N. Casper $9,020,542
FEI Company Vahe A. Sarkissian $8,996,945
PerkinElmer Gregory L. Summe $7,753,792
FEI Company Don R. Kania $7,614,268
AMETEK F.S. Hermance $7,229,094
Applied Biosystems Tony L. White $6,368,341
Beckman Coulter Scott Garrett $5,818,374
Becton Dickinson & Co. Edward J. Ludwig $5,451,042
Average $8,815,326
Short-Term Compensation
Executive Title Salary Bonus
Laboratory Consumables/Equipment
Invitrogen
Gregory T. Lucier COB/CEO $904,615 $0
Kewaunee Scientific
William A. Shumaker P/CEO $294,167 $0
Millipore
Martin D. Madaus COB/P/CEO $680,769 $0
New Brunswick Scientific
David Freedman COB/CEO $288,943 $490,283
James T. Orcutt P/COO $231,650 $91,944
Pall
Eric Krasnoff COB/CEO $816,036 $865,815
Marcus Wilson P/CFO $471,172 $56,192
Sigma-Aldrich
Jai. P. Nagarkatti P/CEO $600,000 $0
David R. Harvey COB $250,000 $500,000
TECHNE
Thomas E. Oland P/CEO $254,100 $0
Average $479,145 $200,423
Diversified Instrumentation
Agilent Technologies
Christopher Van Ingen SVP LifeSci $437,500 $227,839
AMETEK
F.S. Hermance COB/CEO $700,000 $280,000
R.W. Chlebek P/EIG $300,000 $89,000
Danaher
Steven E. Simms EVP $610,000 $0
Mettler-Toledo Int'l
Robert F. Spoerry P/CEO $918,279 $1,431,414
Beat Luethi Head of Lab. $343,417 $355,196
Teledyne Technologies
Aldo Pichelli SVP/COO $280,586 $0
Roper Industries
Brian D. Jellison COB/P/CEO $900,000 $0
Nirel W. Crocker VP/P/Ind.Tech. $315,000 $0
Average $533,865 $264,828
Process/Metrology/Motion Instrumentation
FEI Company
Don R. Kania P/CEO $209,452 $750,000
Vahe A. Sarkissian Former P/CEO $142,921 $0
MTS Systems
Sidney W. Emery, Jr. COB/P/CEO $483,014 $354,307
RAE Systems
Robert I. Chen P/CEO $280,000 $0
Strategic Diagnostics
Matthew H. Knight P/CEO $268,000 $0
Veeco Instruments
Edward H. Braun COB/CEO $650,000 $0
Zygo
J. Bruce Robinson COB/P/CEO $387,813 $347,431
Average $345,886 $207,391
Laboratory Instrumentation
Affymetrix
Stephen P.A. Fodor COB/CEO $606,154 $0
Susan E. Siegel P $463,558 $0
Applied Biosystems
Tony L. White COB/P/CEO $1,096,154 $2,107,432
Catherine M. Burzik SVP/P $554,530 $948,971
Beckman Coulter
Scott Garrett P/CEO $730,366 $0
Becton Dickinson & Co.
Edward J. Ludwig P/CEO $1,020,915 $1,150,000
Vincent A. Forlenza EVP $476,449 $340,000
Bio-Rad Laboratories
Norman Schwartz P/CEO $526,065 $0
David Schwartz COB $515,760 $0
Bruker BioSciences
Frank H. Laukien COB/P/CEO $295,000 $250,000
Caliper Life Sciences
E. Kevin Hrusovsky P/CEO $413,333 $312,000
Cepheid
John L. Bishop D/CEO $400,000 $0
CombiMatrix
Amit Kumar P/CEO $414,413 $0
Dionex
Lukas Braunschweiler P/CEO $407,308 $158,671
Harvard Bioscience
Chane Graziano CEO $486,000 $0
David Green P $400,000 $0
Illumina
Jay T. Flatley P/CEO $463,462 $149,175
Luminex
Patrick J. Balthrop P/CEO $400,000 $192,496
MOCON
Robert L. Demorest COB/P/CEO $245,350 $0
O.I. Corp.
William W. Botts P/CEO $249,039 $0
PerkinElmer
Gregory L. Summe COB/P/CEO $998,077 $0
Robert F. Friel SVP/P LAS $542,115 $0
SEQUENOM
Harry Stylli P/CEO $420,000 $0
Symyx Technologies
Steven D. Goldby COB/CEO $400,000 $0
Isy Goldwasser P $375,000 $0
Thermo Fisher Scientific
Marijin E. Dekkers P/CEO $1,036,539 $2,135,000
Mark N. Casper EVP $614,615 $950,667
Transgenomic
Craig J. Tuttle P/CEO $117,964 $0
Collin J. D'Silva Former P/CEO $230,606 $0
Varian
Garry W. Rogerson P/CEO $535,577 $594,220
Martin O'Donoghue VP/P/Sci.Inst. $270,175 $214,513
Waters
Douglas A. Berthiaume COB/P/CEO $650,000 $0
Arthur G. Caputo EVP/P/Wtrs.Div. $375,000 $0
X-Rite
Thomas J. Vacchiano, Jr. P/CEO $149,039 $0
Michael C. Ferrara Former P/CEO $410,251 $205,000
Average $493,966 $277,376
Short-Term Compensation
Non-
Equity
Executive Incentive Other Total
Laboratory Consumables/Equipment
Invitrogen
Gregory T. Lucier $287,674 $20,493 $1,212,782
Kewaunee Scientific
William A. Shumaker $0 $23,533 $317,700
Millipore
Martin D. Madaus $750,000 $137,837 $1,568,606
New Brunswick Scientific
David Freedman $0 $19,496 $798,722
James T. Orcutt $0 $16,651 $340,245
Pall
Eric Krasnoff $0 $36,140 $1,717,991
Marcus Wilson $0 $88,335 $615,699
Sigma-Aldrich
Jai. P. Nagarkatti $416,874 $271,859 $1,288,733
David R. Harvey $222,955 $65,953 $1,038,908
TECHNE
Thomas E. Oland $0 $0 $254,100
Average $168 $68 $915,349
Diversified Instrumentation
Agilent Technologies
Christopher Van Ingen $0 $8,800 $674,139
AMETEK
F.S. Hermance $952,000 $885,273 $2,817,273
R.W. Chlebek $308,000 $350,012 $1,047,012
Danaher
Steven E. Simms $900,000 $71,300 $1,581,300
Mettler-Toledo Int'l
Robert F. Spoerry $0 $889,512 $3,239,205
Beat Luethi $0 $115,423 $814,036
Teledyne Technologies
Aldo Pichelli $207,767 $197,417 $685,770
Roper Industries
Brian D. Jellison $1,800,000 $213,264 $2,913,264
Nirel W. Crocker $3,151,000 $74,377 $704,377
Average $498,085 $311,709 $1,608,486
Process/Metrology/Motion Instrumentation
FEI Company
Don R. Kania $244,227 $4,899 $1,208,578
Vahe A. Sarkissian $0 $8,854,024 $8,996,945
MTS Systems
Sidney W. Emery, Jr. $0 $16,200 $853,521
RAE Systems
Robert I. Chen $51,437 $17,940 $349,377
Strategic Diagnostics
Matthew H. Knight $40,200 $7,682 $315,882
Veeco Instruments
Edward H. Braun $387,649 $23,431 $1,061,080
Zygo
J. Bruce Robinson $0 $10,800 $746,044
Average $103,369 $1,276,425 $1,933,061
Laboratory Instrumentation
Affymetrix
Stephen P.A. Fodor $0 $26,289 $632,443
Susan E. Siegel $0 $12,006 $475,564
Applied Biosystems
Tony L. White $0 $349,291 $3,552,877
Catherine M. Burzik $0 $128,140 $1,631,641
Beckman Coulter
Scott Garrett $655,000 $339,120 $1,724,486
Becton Dickinson & Co.
Edward J. Ludwig $0 $68,633 $2,239,548
Vincent A. Forlenza $0 $11,137 $827,586
Bio-Rad Laboratories
Norman Schwartz $266,938 $11,774 $804,777
David Schwartz $261,709 $16,325 $793,794
Bruker BioSciences
Frank H. Laukien $0 $11,760 $556,760
Caliper Life Sciences
E. Kevin Hrusovsky $0 $1,325 $726,658
Cepheid
John L. Bishop $41,600 $43,693 $485,293
CombiMatrix
Amit Kumar $0 $0 $414,413
Dionex
Lukas Braunschweiler $0 $0 $565,979
Harvard Bioscience
Chane Graziano $282,000 $14,591 $782,591
David Green $233,000 $22,040 $655,040
Illumina
Jay T. Flatley $0 $4,500 $617,137
Luminex
Patrick J. Balthrop $337,000 $7,292 $936,788
MOCON
Robert L. Demorest $217,490 $11,305 $474,145
O.I. Corp.
William W. Botts $0 $26,775 $275,814
PerkinElmer
Gregory L. Summe $2,806,100 $606,886 $4,411,063
Robert F. Friel $1,170,648 $196,824 $1,909,587
SEQUENOM
Harry Stylli $210,000 $15,959 $645,959
Symyx Technologies
Steven D. Goldby $225,000 $4,400 $629,400
Isy Goldwasser $211,000 $4,400 $590,400
Thermo Fisher Scientific
Marijin E. Dekkers $0 $461,589 $3,633,128
Mark N. Casper $0 $91,026 $1,656,308
Transgenomic
Craig J. Tuttle $25,000 $21,261 $164,225
Collin J. D'Silva $0 $22,115 $252,721
Varian
Garry W. Rogerson $0 $87,470 $1,217,267
Martin O'Donoghue $0 $46,156 $530,844
Waters
Douglas A. Berthiaume $1,625,000 $159,488 $2,434,488
Arthur G. Caputo $787,500 $71,651 $1,234,151
X-Rite
Thomas J. Vacchiano, Jr. $46,500 $6,157 $201,696
Michael C. Ferrara $76,500 $16 $707,775
Average $270,800 $83,354 $1,125,496
Long-Term
Short- Compensation
Term
Compensation Fair Value Fair
Stock Value
% Award. Option
Executive Chg. '06 Award '06
Laboratory Consumables/Equipment
Invitrogen
Gregory T. Lucier -43% $1,328,832 $2,861,864
Kewaunee Scientific
William A. Shumaker 5% $0 $31,267
Millipore
Martin D. Madaus N/A $1,113,189 $1,238,560
New Brunswick Scientific
David Freedman 103% $0 $0
James T. Orcutt 12% $0 $48,450
Pall
Eric Krasnoff 102% $773,001 $1,847,030
Marcus Wilson 0% $828,367 $30,000
Sigma-Aldrich
Jai. P. Nagarkatti 30% $348,095 $560,900
David R. Harvey -21% $0 $868,068
TECHNE
Thomas E. Oland 5% $0 $0
Average -9.9% $439,148 $748,614
Diversified Instrumentation
Agilent Technologies
Christopher Van Ingen 4% $0 $3,276,889
AMETEK
F.S. Hermance 56% $3,119,931 $1,291,890
R.W. Chlebek 86% $189,323 $276,087
Danaher
Steven E. Simms -2% $1,288,202 $2,046,223
Mettler-Toledo Int'l
Robert F. Spoerry 49% $0 $2,137,000
Beat Luethi 10% $0 $961,650
Teledyne Technologies
Aldo Pichelli 52% $190,056 $133,000
Roper Industries
Brian D. Jellison 18% $5,235,196 $1,499,300
Nirel W. Crocker 9% $423,500 $163,560
Average 31% $1,160,690 $1,309,511
Process/Metrology/Motion Instrumentation
FEI Company
Don R. Kania N/A $2,907,000 $3,498,690
Vahe A. Sarkissian N/A $0 $0
MTS Systems
Sidney W. Emery, Jr. -6% $0 $641,160
RAE Systems
Robert I. Chen 0% $0 $0
Strategic Diagnostics
Matthew H. Knight -21% $185,893 $0
Veeco Instruments
Edward H. Braun 4% $590,250 $304,400
Zygo
J. Bruce Robinson 40% $166,400 $462,308
Average 209% $549,935 $700,937
Laboratory Instrumentation
Affymetrix
Stephen P.A. Fodor -2% $333,780 $726,765
Susan E. Siegel 3% $0 $202,390
Applied Biosystems
Tony L. White 15% $2,815,464 $0
Catherine M. Burzik 25% $1,162,512 $0
Beckman Coulter
Scott Garrett 58% $2,525,880 $1,568,008
Becton Dickinson & Co.
Edward J. Ludwig -14% $1,611,420 $1,600,074
Vincent A. Forlenza -10% $241,006 $389,205
Bio-Rad Laboratories
Norman Schwartz 25% $0 $2,791,487
David Schwartz 21% $0 $335,653
Bruker BioSciences
Frank H. Laukien 132% $166,250 $33,250
Caliper Life Sciences
E. Kevin Hrusovsky -13% $230,400 $352,537
Cepheid
John L. Bishop -10% $0 $1,384,760
CombiMatrix
Amit Kumar 4% $0 $571,915
Dionex
Lukas Braunschweiler -13% $0 $2,135,918
Harvard Bioscience
Chane Graziano 63% $0 $907,350
David Green 66% $0 $604,900
Illumina
Jay T. Flatley 8% $0 $3,654,750
Luminex
Patrick J. Balthrop -4% $569,586 $893,472
MOCON
Robert L. Demorest 23% $0 $50,850
O.I. Corp.
William W. Botts 11% $0 $0
PerkinElmer
Gregory L. Summe 52% $1,433,979 $1,908,750
Robert F. Friel 146% $692,741 $1,149,848
SEQUENOM
Harry Stylli 160% $0 $1,423,684
Symyx Technologies
Steven D. Goldby -4% $967,890 $0
Isy Goldwasser 1% $967,890 $0
Thermo Fisher Scientific
Marijin E. Dekkers 47% $4,246,328 #########
Mark N. Casper 34% $1,873,584 $5,490,650
Transgenomic
Craig J. Tuttle N/A $0 $18,000
Collin J. D'Silva 11% $0 $0
Varian
Garry W. Rogerson 11% $467,610 $2,693,800
Martin O'Donoghue 4% $170,040 $864,600
Waters
Douglas A. Berthiaume 138% $0 $2,041,401
Arthur G. Caputo 118% $0 $1,835,000
X-Rite
Thomas J. Vacchiano, Jr. N/A $0 $783,650
Michael C. Ferrara 77% $526,680 $737,700
Average 25% $600,087 $1,414,972
Options
Op. Profit
Exerc.
Total '06 '06 %
Executive Comp. ($000) ($M) Chg.
Laboratory Consumables/Equipment
Invitrogen
Gregory T. Lucier $5,403,478 $0 -$158 NM
Kewaunee Scientific
William A. Shumaker $348,967 $0 $1 NM
Millipore
Martin D. Madaus $3,920,355 $0 $144 2%
New Brunswick Scientific
David Freedman $798,722 $0 $6 43%
James T. Orcutt $388,695 $92 $6 43%
Pall
Eric Krasnoff $4,338,022 $0 $233 13%
Marcus Wilson $1,474,066 $46 $233 13%
Sigma-Aldrich
Jai. P. Nagarkatti $2,197,728 $238 $403 11%
David R. Harvey $1,906,976 $1,701 $403 11%
TECHNE
Thomas E. Oland $254,100 $20,928 $109 11%
Average $2,103,111 $2,300 $105 -21%
Diversified Instrumentation
Agilent Technologies
Christopher Van Ingen $3,951,028 $0 $240 22%
AMETEK
F.S. Hermance $7,229,094 $0 $309 32%
R.W. Chlebek $1,512,422 $723 $309 32%
Danaher
Steven E. Simms $4,915,725 $14,528 $262 89%
Mettler-Toledo Int'l
Robert F. Spoerry $5,376,205 $14,542 $214 10%
Beat Luethi $1,775,686 $957 $214 10%
Teledyne Technologies
Aldo Pichelli $1,008,826 $495 $83 29%
Roper Industries
Brian D. Jellison $9,647,760 $0 $338 27%
Nirel W. Crocker $1,291,437 $1,294 $23 10%
Average $4,078,687 $3,616 $241 32%
Process/Metrology/Motion Instrumentation
FEI Company
Don R. Kania $7,614,268 $0 $23 NM
Vahe A. Sarkissian $8,996,945 $121 $23 NM
MTS Systems
Sidney W. Emery, Jr. $1,494,681 $125 $56 5%
RAE Systems
Robert I. Chen $349,377 $0 $43 NM
Strategic Diagnostics
Matthew H. Knight $501,775 $0 $1 -14%
Veeco Instruments
Edward H. Braun $1,955,730 $35 $22 103%
Zygo
J. Bruce Robinson $1,374,752 $0 $19 25%
Average $3 $40 $20 266
Laboratory Instrumentation
Affymetrix
Stephen P.A. Fodor $1,692,988 $465 -$19 NM
Susan E. Siegel $677,954 $133 -$19 NM
Applied Biosystems
Tony L. White $6,368,341 $4,589 $297 6%
Catherine M. Burzik $2,794,153 $518 $297 6%
Beckman Coulter
Scott Garrett $5,818,374 $518 $263 28%
Becton Dickinson & Co.
Edward J. Ludwig $5,451,042 $0 $1,050 2%
Vincent A. Forlenza $1,457,797 $0 $213 22%
Bio-Rad Laboratories
Norman Schwartz $3,596,264 $0 $146 53%
David Schwartz $1,129,447 $0 $146 53%
Bruker BioSciences
Frank H. Laukien $756,260 $0 $31 188%
Caliper Life Sciences
E. Kevin Hrusovsky $1,309,595 $0 -$30 NM
Cepheid
John L. Bishop $1,870,053 $0 -$30 NM
CombiMatrix
Amit Kumar $986,328 $0 -$22 NM
Dionex
Lukas Braunschweiler $2,701,897 $0 $56 -14%
Harvard Bioscience
Chane Graziano $1,689,941 $0 $9 10%
David Green $1,259,940 $0 $9 10%
Illumina
Jay T. Flatley $4,271,887 $0 $38 N/A
Luminex
Patrick J. Balthrop $2,399,846 $0 -$1 NM
MOCON
Robert L. Demorest $524,995 $26 $5 32%
O.I. Corp.
William W. Botts $275,814 $0 $3 6%
PerkinElmer
Gregory L. Summe $7,753,792 $0 $153 9%
Robert F. Friel $3,752,176 $0 $115 5%
SEQUENOM
Harry Stylli $2,069,643 $0 -$19 NM
Symyx Technologies
Steven D. Goldby $1,597,290 $685 $7 -55%
Isy Goldwasser $1,558,290 $585 $7 -55%
Thermo Fisher Scientific
Marijin E. Dekkers $20,253,106 $12,159 $242 -8%
Mark N. Casper $9,020,542 $5,305 $242 -8%
Transgenomic
Craig J. Tuttle $182,225 $0 -$3 NM
Collin J. D'Silva $252,721 $0 -$3 NM
Varian
Garry W. Rogerson $4,378,677 $2,223 $73 21%
Martin O'Donoghue $1,565,484 $713 $60 19%
Waters
Douglas A. Berthiaume $4,475,889 $5,184 $295 4%
Arthur G. Caputo $3,069,151 $3,830 $295 4%
X-Rite
Thomas J. Vacchiano, Jr. $985,346 $0 -$23 NM
Michael C. Ferrara $1,972,155 $0 -$23 NM
Average $3,140,554 $1,055 $110 3%
Top 10 Short-Term Compensation, 2006
Company Executive Total Pay
PerkinElmer Gregory L. Summe $4,411,063
Thermo Fisher Scientific Marijin E. Dekkers $3,633,128
Applied Biosystems Tony L. White $3,552,877
Mettler-Toledo Int'l Robert F. Spoerry $3,239,205
Roper Industries Brian D. Jellison $2,913,264
AMETEK F.S. Hermance $2,817,273
Waters Douglas A. Berthiaume $2,434,488
Becton Dickinson & Co. Edward J. Ludwig $2,239,548
PerkinElmer Robert F. Friel $1,909,587
Beckman Coulter Scott Garrett $1,724,486
Average $2,887,492
Top 10 Short-Term Raises, 2006
Company Executive % Change
SEQUENOM Harry Stylli 160%
PerkinElmer Robert F. Friel 146%
Waters Douglas A. Berthiaume 138%
Bruker BioSciences Frank H. Laukien 132%
Waters Arthur G. Caputo 118%
New Brunswick Scientific David Freedman 103%
Pall Eric Krasnoff 102%
AMETEK R.W. Chlebek 86%
X-Rite Michael C. Ferrara 77%
Harvard Bioscience David Green 66%
Average 118%
Top 10 Fair Value Option Grant Recipients, 2006
Company Executive Fair Value
Thermo Fisher Scientific Marijin E. Dekkers $12,373,650
Thermo Fisher Scientific Mark N. Casper $5,490,650
Illumina Jay T. Flatley $3,654,750
FEI Company Don R. Kania $3,498,690
Agilent Technologies Christopher van Ingen $3,276,889
Invitrogen Gregory T. Lucier $2,861,864
Bio-Rad Laboratories Norman Schwartz $2,791,487
Varian Garry W. Rogerson $2,693,800
Mettler-Toledo Int'l Robert F. Spoerry $2,137,000
Dionex Lukas Braunschweiler $2,135,918
Average $4,091,470
Top 10 Operating Profits in Proportion to Compensation, 2006
Company Executive Op. Prof./Pay *
CEOs
Becton Dickinson & Co. Edward J. Ludwig 469
TECHNE Thomas E. Oland 427
Sigma-Aldrich Jai. P. Nagarkatti 312
Bio-Rad Laboratories Norman Schwartz 182
Beckman Coulter Scott Garrett 152
Average 308
Non-CEOs
Sigma-Aldrich David R. Harvey 388
Pall Marcus Wilson 379
Agilent Technologies Christopher van Ingen 356
AMETEK R.W. Chlebek 295
Mettler-Toledo Int'l Beat Luethi 263
Average 336
* Operating profit earned per dollar of short-term compensation.
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion